25024-98-0

Upstream product

• 35386-24-4 1-(2-Methoxyphenyl)piperazine 
• 5414-21-1 5-bromopentan-1-nitrile 

Downstream Products

• 21098-02-2 5‐[4‐(2‐methoxyphenyl)piperazin‐1‐yl]pentan‐1‐amine 
• 188708-22-7 5-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-pentanethioic acid amide 
• 188708-21-6 1-(4-aminocarbonylbutyl)-4-(2-methoxy-phenyl)piperazine 

Relevant academic research and scientific papers

New organometallic imines of rhenium(i) as potential ligands of GSK-3β: Synthesis, characterization and biological studies

Substituted amino-piperazine derivatives were synthesized and used as precursors for the preparation of a series of new organometallic Re(i) imine complexes with the general formula [(η5-C5H4CHN-(CH2)5-Pz-R)Re(CO)3] (Pz-R: -alkyl or aryl piperazine). The piperazine-based ligands were designed to be potential inhibitors of GSK-3β kinase. All the ligands and complexes were fully characterized and evaluated against the HT-29 and PT-45 cancer cell lines, in which GSK-3β plays a crucial role. In this context, we carried out biological evaluation using the MTT colorimetric assay. In terms of structure activity relationship, our findings indicated improved biological activity when aromaticity increased in the organic ligands (3d). In addition, the presence of the rhenium fragment in the imines (5a-d) leads to better activity with IC50 values in the range of 25-100 μM. In addition, our experimental studies were complemented by computational studies, where the volume and electrostatic surface of the organic ligands and organometallic compounds as well as their binding to the kinase protein are calculated.

Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands

Dopamine is an important neurotransmitter in the human brain and its altered concentrations can lead to various neurological diseases. We studied the binding of novel compounds at the dopamine D2 (D2R) and D3 (D3/sub

1(HETERO)ARYL-4-(CONDENSED THIAZOL-2-YLALKYL)-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF 5-HT1A-RECEPTOR MEDIATED DISORDERS

Aryl and heteroaryl piperazine derivatives of formula (I) wherein, R1 is hydrogen, halogen, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, hydroxy or C1-C6 mono- or di- alkylamino; m is zero or an integer from 1 to 3; n is an integer from 1

Synthesis of arylpiperazines with a terminal naphthothiazole group and their evaluation on 5-HT, DA and α receptors

The synthesis, affinities for 5-HT(1A), 5-HT2, D1, D2, α1 and α2 receptors and structure-activity relationships are described for a series of arylpiperazines substituted on the N-4 atom with an ω-(2-n